The “break the chain” video shows how easy it is for hospital-acquired infections like MRSA and Clostridium difficile to be spread. Please make sure you wash …
The global infection control market is estimated to reach $16.7 Billion by 2020, growing at a CAGR of 6.7% during the forecast period (2015 to 2020)The rise in chronic diseases, increase in the number of surgeries performed, increase in the occurrence of hospital-acquired infections, and aging population are the major drivers for the growth of infection control market. Similarly, with a rise in the awareness of food quality and an increase in the exports of exotic fruits and vegetables across countries, the need for food sterilization and disinfection has risen. Hospitals and medical devices play a vital role in the infection control market.
Image courtesy of globenewswire.com
As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, researchers have raced to find treatments for the deadly virus, which has killed more than 400 people since it was first discovered three years ago in Saudi Arabia.
Now, scientists at the University of Maryland School of Medicine and Regeneron Pharmaceuticals, Inc., have discovered and validated two therapeutics that show early promise in preventing and treating the disease, which can cause severe respiratory symptoms, and has a death rate of 40 percent. These therapeutics are the first to succeed in protecting and treating animal models of the MERS virus. The study appears today in the latest issue of the journal Proceedings of the National Academy of Sciences (PNAS).
These therapeutics are the first to succeed in protecting and treating animal models of the MERS virus. This research, done in collaboration with Regeneron, a biopharmaceutical company based in Tarrytown, New York, used several of the company’s proprietary technologies to search for and validate effective antibodies targeting the virus. MERS was first discovered in 2012 in Saudi Arabia.
Image courtesy of infectioncontroltoday.com